Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Plos One|June 10, 2022
VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patientsYi Ding, Leticia Oliveira-Ferrer, Eike Vettorazzi, et al.BMC Women'S Health|July 3, 2025
Anogenital high-risk HPV prevalence and screening considerations in female transplant recipients: a cross-sectional studyChristoph Hillen, Charlotte Sachs, Anna Jaeger, et al.Journal of Lower Genital Tract Disease|May 9, 2017
Oral Human Papillomavirus in Women With High-Grade Cervical Intraepithelial NeoplasiaLinn Woelber, Julia Breuer, Thomas Meyer, et al.Oncotarget|November 16, 2017
Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancerKatharina Prieske, Stefan Prieske, Simon A Joosse, et al.Cancers|December 24, 2021
Transcriptome Analysis in Vulvar Squamous Cell CancerKatharina Prieske, Malik Alawi, Anna Jaeger, et al.Archives of Gynecology and Obstetrics|September 1, 2018
Participation of elderly gynecological cancer patients in clinical trialsKatharina Prieske, Fabian Trillsch, Gülten Oskay-Özcelik, et al.Cancers|August 26, 2022
Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer PatientsMarkus Leffers, Johanna Herbst, Jolanthe Kropidlowski, et al.Clinical Chemistry|January 4, 2024
Detection of Multiple HPV Types in Liquid Biopsies of Cervical NeoplasiaJohanna Herbst, Vanessa Vohl, Maroje Krajina, et al.Cancers|February 20, 2020
Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer PatientsClaudia Koch, Simon A Joosse, Svenja Schneegans, et al.Oncogene|April 3, 2026
Pre-operative circulating tumor cells predict worse treatment outcome in patients with high-grade serous ovarian cancerAnnabelle Lobermeyer, Jenna Sophie Schöllhorn, Paul N Rademacher, et al.Pageof 5